CRISPR

YTD

ALL

Trade CRISPR 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

393

Employees393

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

393

Employees393

CRSP Key Statistics

Market cap

6.21B

Market cap6.21B

Price-Earnings ratio

-12.47

Price-Earnings ratio-12.47

Dividend yield

—

Dividend yield—

Average volume

2.33M

Average volume2.33M

High today

$68.88

High today$68.88

Low today

$66.85

Low today$66.85

Open price

$68.55

Open price$68.55

Volume

1.34M

Volume1.34M

52 Week high

$78.48

52 Week high$78.48

52 Week low

$30.04

52 Week low$30.04

CRSP News

TipRanks 6h

Crispr Therapeutics AG Faces Stock Price Slump

Crispr Therapeutics AG ( (CRSP) ) has fallen by -8.60%. Read on to learn why. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...

Nasdaq 2d

December 5th Options Now Available For CRISPR Therapeutics

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading today, for the December 5th expiration. At Stock Options Channel , our YieldBoo...

Simply Wall St 5d

Is CRISPR Therapeutics' US$600 Million Stock Sale and CTX460 Results Shaping Its Path as a Gene Editing Leader?

In October 2025, CRISPR Therapeutics announced new preclinical results for its SyNTase™ gene editing platform targeting Alpha-1 Antitrypsin Deficiency, alongsid...

Analyst ratings

57%

of 30 ratings

Buy

56.7%

Hold

40%

Sell

3.3%

People also own

Based on the portfolios of people who own CRSP. This list is generated using Robinhood data, and it’s not a recommendation.

Intellia Therapeutics